We are live on ! Find out more
VYNT

Vyant Bio, Inc. Common Stock

Delisted

VYNT was delisted on the 12th of May, 2023.

29 hedge funds and large institutions have $8.33M invested in Vyant Bio, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

6% less funds holding

Funds holding: 3129 (-2)

21% less capital invested

Capital invested by funds: $10.5M → $8.33M (-$2.18M)

29% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 7

Holders
29
Holders Change
-2
Holders Change %
-6.45%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
8
Reduced
5
Closed
7
Calls
Puts
Net Calls
Net Calls Change

VYNT Hedge Fund Activity: Q1 2015 in Review

29 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio, Inc. Common Stock (VYNT) for Q1 2015, worth a combined $8.33M — down 21% from $10.5M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of VYNT and 5 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 8 added.

The largest buyer was Granite Investment Partners, opening a new position worth an estimated $873K. The largest seller was Bank of Montreal, exiting entirely with an estimated $4.12M sold.

  • 29 institutional investors held Vyant Bio, Inc. Common Stock (VYNT) as of Q1 2015, down from 31 in Q4 2014.
  • Funds reported $8.33M of Vyant Bio, Inc. Common Stock stock for Q1 2015, down 21% quarter-over-quarter.
  • 5 funds opened new Vyant Bio, Inc. Common Stock positions in Q1 2015 and 7 closed out, a net change of -2 holders.
  • The largest Vyant Bio, Inc. Common Stock buyer in Q1 2015 was Granite Investment Partners, an estimated $873K added.
  • The largest Vyant Bio, Inc. Common Stock seller in Q1 2015 was Bank of Montreal, an estimated $4.12M sold.

Based on aggregated 13F filings for Q1 2015.